Kenneth A. Stauderman - 24 Jun 2025 Form 4 Insider Report for CalciMedica, Inc. (CALC)

Role
Chief Scientific Officer
Signature
/s/ John Dunn, Attorney-in-Fact
Issuer symbol
CALC
Transactions as of
24 Jun 2025
Transactions value $
$0
Form type
4
Filing time
26 Jun 2025, 18:29:14 UTC
Previous filing
25 Apr 2025
Next filing
02 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stauderman Kenneth A. Chief Scientific Officer CALCIMEDICA, INC., 505 COAST S. BLVD. #307, LA JOLLA /s/ John Dunn, Attorney-in-Fact 26 Jun 2025 0001969388

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CALC Employee Stock Option (Right to Buy) Award $0 +47.1K $0.00 47.1K 24 Jun 2025 Common Stock 47.1K $1.53 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant was approved by the Board of Directors of CalciMedica, Inc. (the "Company") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the "Amended 2023 EIP") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025.
F2 Immediately exercisable.